IL6 and breast carcinoma: Another group showed an important crosstalk axis where CAFs secrete IL-6, and breast cancer cells develop radioresistance through CAF mediated activation of the STAT3 pathway; blocking this IL-6-STAT3 axis decreased breast cancer growth and increased susceptibility to treatment.21